Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M509Revenue $M219Net Margin (%)-18.7Altman Z-Score0.6
Enterprise Value $M675EPS $-1.4Operating Margin %-7.3Piotroski F-Score5
P/E(ttm)--Beneish M-Score152Pre-tax Margin (%)-18.2Higher ROA y-yY
Price/Book3.410-y EBITDA Growth Rate %--Quick Ratio2.4Cash flow > EarningsY
Price/Sales2.35-y EBITDA Growth Rate %-19.1Current Ratio3.7Lower Leverage y-yN
Price/Free Cash Flow20.9y-y EBITDA Growth Rate %--ROA % (ttm)-11.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-28.0Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M28.6ROIC % (ttm)-12.3Gross Margin Increase y-yN

Gurus Latest Trades with AEGR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AEGRMichael Price 2014-12-31 Sold Out -1%$19.66 - $35.02
($25.02)
$ 17.77-29%Sold Out0
AEGRGeorge Soros 2014-12-31 Sold Out -0.01%$19.66 - $35.02
($25.02)
$ 17.77-29%Sold Out0
AEGRJoel Greenblatt 2014-12-31 Sold Out $19.66 - $35.02
($25.02)
$ 17.77-29%Sold Out0
AEGRGeorge Soros 2014-09-30 Buy 0.01%$26.93 - $35.65
($30.96)
$ 17.77-43%New holding25,000
AEGRJoel Greenblatt 2014-09-30 Buy $26.93 - $35.65
($30.96)
$ 17.77-43%New holding10,964
AEGRMichael Price 2014-03-31 Buy 1.1%$43.65 - $73.75
($59.26)
$ 17.77-70%New holding200,000
AEGRGeorge Soros 2012-06-30 Sold Out -0.01%$11.76 - $16.96
($14.02)
$ 17.7727%Sold Out0
AEGRGeorge Soros 2011-06-30 Buy 0.01%$15.29 - $21.85
($17.62)
$ 17.771%New holding37,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AEGR is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


AEGR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Fitzpatrick Mark J.CFO 2014-08-19Buy1,150$30.64-42 view
Beer Marc DCEO 2014-07-31Buy10,000$33.65-47.19 view
Beer Marc DCEO 2014-06-03Buy10,000$30.12-41 view
Beer Marc DCEO 2014-05-27Buy10,000$31.59-43.75 view
Beer Marc DCEO 2014-05-20Buy10,000$30.53-41.79 view
Beer Marc DCEO 2014-05-08Buy30,000$35.31-49.67 view
VANLENT ANNEDirector 2014-05-08Buy4,000$33.78-47.39 view
Fraser CraigPres., US/Int. Comm. & Manuf. 2014-04-30Sell2,250$43.55-59.2 view
Fraser CraigPres., US/Int. Comm. & Manuf. 2014-03-31Sell2,250$46.2-61.54 view
Sumeray MarkChief Medical Officer 2014-03-14Sell2,000$51.34-65.39 view

Quarterly/Annual Reports about AEGR:

News about AEGR:

Articles On GuruFocus.com
Gilead Sciences Releases Impressive Results for Hepatitis C Drug Nov 12 2014 
Weekly CEO Buys Highlight: APD, OCUL, CNMD, OPK, AEGR Aug 04 2014 
Weekly CEO Buys Highlight: GEO, TRUE, BANC, AEGR, CLMS Jun 02 2014 
Three CEOs Reporting Large Insider Buys May 22 2014 
Four CEOs Reporting Large Insider Buys May 09 2014 
100 Stocks at All-Time Highs | 60 Dividend Stocks Below the Results Feb 19 2013 
My 3 Favorite Dividend Stocks at All-Time-Highs | Stock List Dec 27 2012 
Weekly CFO Buys Highlight: RXN, XBKS, STAG, AEGR, PZG Apr 02 2012 

More From Other Websites
AEGERION PHARMACEUTICALS, INC. Files SEC form 8-K/A, Change in Directors or Principal Officers Aug 27 2015
10-Q for Aegerion Pharmaceuticals, Inc. Aug 19 2015
AEGERION PHARMACEUTICALS, INC. Files SEC form 8-K/A, Results of Operations and Financial Condition,... Aug 17 2015
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program Aug 12 2015
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program Aug 12 2015
AEGERION PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Aug 11 2015
Aegerion's Loss Narrower than Expected, View Maintained - Analyst Blog Aug 06 2015
Edited Transcript of AEGR earnings conference call or presentation 5-Aug-15 9:00pm GMT Aug 06 2015
Aegerion Pharmaceuticals Inc Earnings Call scheduled for 5:00 pm ET today Aug 05 2015
Aegerion Pharmaceuticals Announces Second Quarter 2015 Financial Results Aug 05 2015
AEGERION PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 05 2015
Aegerion Pharmaceuticals Announces Second Quarter 2015 Financial Results Aug 05 2015
Q2 2015 Aegerion Pharmaceuticals Inc Earnings Release - After Market Close Aug 05 2015
Why Earnings Season Could Be Great for Aegerion Pharmaceuticals (AEGR) - Tale of the Tape Aug 04 2015
What's in Store for Aegerion (AEGR) This Earnings Season? - Analyst Blog Aug 03 2015
Will Endocyte (ECYT) Earnings Surprise Investors in Q2? - Analyst Blog Aug 03 2015
AEGERION PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other... Jul 30 2015
Jefferies Upgrades Aegerion Pharma To Buy, Sees Positively Skewed Risk/Reward Jul 28 2015
Aegerion Pharma upgraded by Jefferies Jul 28 2015
5 Hated Earnings Stocks You Should Love Jul 27 2015
Aegerion Pharmaceuticals Announces Leadership Changes to Support the Next Stage of Growth Jul 27 2015
Aegerion Pharmaceuticals Announces Leadership Changes to Support the Next Stage of Growth Jul 27 2015
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program Jul 13 2015
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program Jul 13 2015
AEGERION PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers,... Jun 29 2015
Aegerion Pharmaceuticals Appoints Gregory Perry as Chief Financial Officer Jun 25 2015
Aegerion Pharmaceuticals Announces Key Additions to Medical Affairs and Drug Safety Jun 16 2015
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program Jun 11 2015
Aegerion Pharmaceuticals Announces Presentation at the Jefferies 2015 Healthcare Conference May 27 2015
Aegerion Pharmaceuticals Achieves Primary Endpoint in Phase III Study of Lomitapide in Japanese... May 26 2015
Aegerion Pharmaceuticals Announces Resignation of Chief Financial Officer May 14 2015
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program May 11 2015
Aegerion Pharmaceuticals Announces First Quarter 2015 Financial Results May 04 2015
Aegerion reports 1Q loss May 04 2015
Aegerion Pharmaceuticals to Present at Upcoming Investor Conferences May 04 2015
Aegerion Pharmaceuticals to Announce First Quarter 2015 Financial Results on Monday, May 4 Apr 21 2015
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program Apr 15 2015
Jorge Plutzky, M.D., Appointed to Aegerion Pharmaceuticals' Board of Directors Apr 09 2015
Aegerion Pharmaceuticals Reaches Agreement With Sarissa Capital Mar 30 2015
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program Mar 10 2015
Aegerion Pharmaceuticals Observes Rare Disease Day Feb 28 2015
Aegerion reports 4Q loss Feb 26 2015
Aegerion Pharmaceuticals Announces Fourth Quarter and Full Year 2014 Financial Results Feb 26 2015
Aegerion tops 3Q profit forecasts Oct 31 2014

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK